High hemoglobin glycation index is associated with increased risk of diabetes: A population-based cohort study in China.


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 27 10 2022
accepted: 08 02 2023
entrez: 13 3 2023
pubmed: 14 3 2023
medline: 15 3 2023
Statut: epublish

Résumé

The hemoglobin glycation index (HGI) quantifies the mismatch between glycated hemoglobin A1c and average glycemia among individuals. Currently, it is unknown the potential role of HGI in exhaustively evaluating the progression of glucose metabolism/the risk of developing diabetes mellitus. Therefore, this study aimed to investigate the association between HGI and the risk of incident diabetes. A total of 7,345 participants aged at least 40 years and without diabetes were divided into three groups according to the tertile of their baseline HGI level and followed for a median of 3.24 years to track new-onset diabetes. Using multivariate Cox regression analyses, we explored the association between the HGI, both categorized and continuous, and incident diabetes. During follow-up, 742 subjects (263 males and 479 females) developed diabetes mellitus. Higher HGI was associated with an increased risk of diabetes, even when adjusted for confounding factors, and every standard deviation increase in HGI was associated with a significant risk increase of 30.6% for diabetes (hazard ratio 1.306, 95% confidence interval 1.232-1.384). Participants with a higher HGI were at a higher risk of future diabetes, irrespective of their glycemic conditions. Consequently, HGI may be employed to identify individuals at high risk for diabetes.

Identifiants

pubmed: 36909319
doi: 10.3389/fendo.2023.1081520
pmc: PMC9999023
doi:

Substances chimiques

Blood Glucose 0
Glycated Hemoglobin 0
glycated hemoglobin C 0
Hemoglobin C 9008-00-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1081520

Informations de copyright

Copyright © 2023 Lin, Wang, Jia, Wang, He, Mu and Dou.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Diabetes Care. 2004 Jun;27(6):1259-64
pubmed: 15161772
J Diabetes Complications. 2002 Sep-Oct;16(5):313-20
pubmed: 12200073
J Clin Endocrinol Metab. 2020 Mar 1;105(3):
pubmed: 31965161
Diabetologia. 2018 Apr;61(4):780-789
pubmed: 29308539
Diabetes Care. 2021 Jan;44(Suppl 1):S15-S33
pubmed: 33298413
Front Cell Dev Biol. 2021 Feb 22;9:624184
pubmed: 33692997
Nat Rev Drug Discov. 2014 Jun;13(6):465-76
pubmed: 24854413
Diabetes Res Clin Pract. 2021 Oct;180:109039
pubmed: 34481909
Science. 1992 Oct 23;258(5082):651-3
pubmed: 1411574
Biomed Pharmacother. 2018 Dec;108:656-662
pubmed: 30245465
Endocrinol Diabetes Metab. 2021 Oct;4(4):e00299
pubmed: 34558807
PLoS One. 2017 Apr 20;12(4):e0175547
pubmed: 28426788
Diab Vasc Dis Res. 2020 Sep-Oct;17(9):1479164120958625
pubmed: 32985267
Clin Endocrinol (Oxf). 2019 Aug;91(2):271-277
pubmed: 31046138
Diabetes Care. 2015 Jun;38(6):1067-74
pubmed: 25887355
J Diabetes Complications. 2018 Oct;32(10):906-910
pubmed: 30121206
Diabetes Care. 2011 Aug;34(8):1712-6
pubmed: 21715524
J Clin Endocrinol Metab. 2015 Jun;100(6):2364-71
pubmed: 25867810
Diabetologia. 1990 Apr;33(4):208-15
pubmed: 2347434
Diabetes Res Clin Pract. 2017 Dec;134:53-61
pubmed: 28993156
Diabetes Care. 2011 Aug;34(8):1816-20
pubmed: 21636794
Diabetes Care. 1999 Mar;22 Suppl 2:B65-71
pubmed: 10097902
Front Cardiovasc Med. 2021 May 28;8:690689
pubmed: 34124211
Diabetes Care. 2006 Feb;29(2):352-5
pubmed: 16443886
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1760-5
pubmed: 22815341
J Diabetes. 2015 Mar;7(2):143-4
pubmed: 25331174
J Diabetes. 2014 Mar;6(2):147-57
pubmed: 24237858
Diabetes Care. 2011 Feb;34(2):518-23
pubmed: 21270207

Auteurs

Lu Lin (L)

Department of Endocrinology, The First Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Department of Endocrinology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.

Anping Wang (A)

Department of Endocrinology, The First Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Xiaomeng Jia (X)

Center for Endocrine Metabolism and Immune Disease, Beijing Luhe Hospital, Capital Medical University, Beijing, China.

Haibin Wang (H)

Department of endocrinology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Yan He (Y)

Department of Epidemiology and Biostatistics, School of Public Health, Capital Medical University, Beijing, China.
Municipal Key Laboratory of Clinical Epidemiology, Beijing, China.

Yiming Mu (Y)

Department of Endocrinology, The First Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Jingtao Dou (J)

Department of Endocrinology, The First Medical Center, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH